A Randomized, Parallel-Cohort Phase 1 Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute Graft Versus Host Disease

Trial Profile

A Randomized, Parallel-Cohort Phase 1 Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute Graft Versus Host Disease

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 22 Jul 2017

At a glance

  • Drugs Itacitinib (Primary) ; Methylprednisolone; Prednisone
  • Indications Graft-versus-host disease
  • Focus Adverse reactions; Proof of concept
  • Sponsors Incyte Corporation
  • Most Recent Events

    • 17 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
    • 25 Jun 2017 Results of 21-marker FACS analysis, presented at the 22nd Congress of the European Haematology Association.
    • 09 Aug 2016 According to an Incyte Corporation media release, initial data from this trial is expected before the end of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top